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Background: Morning headache is associated with obstructive sleep apnoea syndrome (OSAS); however, OSAS
patients present with various characteristics of morning headache, and they often do not fulfil the International
Classification of Headache Disorders (ICHD)-2 criteria for “sleep apnoea headache”. The aims of this study were to
assess the new ICHD-3 beta criteria for sleep apnoea headache in OSAS patients and to evaluate the differences
with the ICHD-2.
Methods: We conducted a cross-sectional survey regarding morning and sleep apnoea headaches that included
235 OSAS outpatients receiving continuous positive airway pressure (CPAP) treatment. The presence of morning
headache was evaluated by reviewing the medical records before administration of CPAP treatment.
Results: Of all of the OSAS patients, 48 (20.4 %) reported morning headaches. Of the 48 patients with morning
headaches, 29 (60.4 %) and 39 (81.3 %) fulfilled the ICHD-2 and ICHD-3 beta criteria for sleep apnoea headache,
respectively. The increased frequency of individuals who qualified for diagnosis was likely attributable to the
extension of headache duration from 30 min to 4 h. The severity of OSAS was not associated with the presence
of sleep apnoea headache.
Conclusions: The utilisation of ICHD-3 beta criteria is clinically useful for diagnosing sleep apnoea headache in
patients with OSAS. Applying the ICHD-3 beta criteria was of clinical significance when considering the marked
response of these headaches to CPAP therapy. The cause of sleep apnoea headache remains to be elucidated.
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Morning headache has been recognised as an obstructive
sleep apnoea syndrome (OSAS)-related symptom, in
addition to daytime sleepiness and snoring. However, pre-
vious reports have attributed morning headaches to differ-
ent causes: nocturnal desaturation, hypercapnia or OSAS
severity [1]; non-OSAS sleep disorders or non-specific
symptoms related to primary/secondary headaches [2];
and psychiatric disorders, such as depression [3]. The* Correspondence: keisuke@dokkyomed.ac.jp
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provided the original work is properly creditedappropriate management of OSAS in patients with
chronic headache is also clinically important because in
some patients, continuous positive airway pressure
(CPAP) treatment is effective at improving their head-
aches [4]. In the International Classification of Headache
Disorders, second edition, (ICHD-2) [5], headaches upon
awakening in the morning and during sleep related to
OSAS were included as “sleep apnoea headache” (Table 1).
The characteristics of sleep apnoea headaches are bilateral
pain that is pressing rather than pulsating, short duration
(<30 min) and a frequency greater than 15 days per
month. They resolve within 72 h after effective treatment
of OSAS.icle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Table 1 Diagnostic criteria for sleep apnoea headache
according to the ICHD-2 (code 10.1.3) and the percentage of
OSAS patients
Diagnostic criteria Morning
headache (n = 48)
A. Recurrent headache with at least one of the
following characteristics and fulfilling criteria
C and D (sleep apnoea headache):
n = 29 (60.4 %)
1. occurs on > 15 days per month n =12 (25.0 %)
2. bilateral, pressing quality and not accompanied
by nausea, photophobia or phonophobia
n = 20 (41.7 %)
3. each headache resolves within 30 min n = 15 (31.3 %)
B. Sleep apnoea (Respiratory Disturbance Index≥ 5)
demonstrated by overnight polysomnography
n = 48 (100 %)
C. Headache is present upon awakening n = 48 (100 %)
D. Headache ceases within 72 h and does not recur
after effective treatment of sleep apnoea
n = 39 (81.3 %)
Table 2 Diagnostic criteria for sleep apnoea headache





A. Headache present on awakening after sleep
and fulfilling criterion C (Sleep apnoea headache)
n = 39
(81.3 %)




C. Evidence of causation demonstrated by at least
two of the following:
n = 39
(81.3 %)
1. Headache has developed in temporal relation to
the onset of sleep apnoea
2. Either or both of the following:
a) Headache has worsened in parallel with worsening
of sleep apnoea
b) Headache has significantly improved or remitted in
parallel with improvement in or resolution of sleep apnoea
3. Headache has at least one of the following three
characteristics:
a) Recurs on > 15 days per month n = 12
(25.0 %)




(iii) not accompanied by nausea, photophobia or
phonophobia
c) Resolves within 4 h n = 25
(52.1 %)
D. Not better accounted for by another ICHD-3 diagnosis
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various characteristics of morning headache that often do
not fulfil the ICHD-2 criteria for “sleep apnoea headache”;
however, most of their morning headaches respond well
to CPAP treatment. Likewise, some investigators have sug-
gested that not all characteristics and frequencies of
morning headache fit the definition of “sleep apnoea head-
ache” [1, 6]. In light of these observations, the definition
of sleep apnoea headache has been slightly modified in the
latest ICHD-3 beta version (3 beta) [7], which defines
sleep apnoea headache as a morning headache, usually bi-
lateral and with a duration of less than 4 h, caused by
sleep apnoea with no time restriction on headache
improvement following appropriate therapy for OSAS
(Table 2). However, no studies have been designed to
compare these two sets of criteria for diagnosing sleep ap-
noea headache.
The aims of this study were to assess the new ICHD-3
beta criteria for sleep apnoea headache in OSAS patients
and to evaluate the differences with the ICHD-2 criteria.
Methods
We conducted a cross-sectional survey of morning and
sleep apnoea headaches between July 2012 and March
2013. This study was approved by the Dokkyo Medical
University institutional review board and conducted in
accordance with the Declaration of Helsinki. All partici-
pants provided written informed consent to participate
in the study. Patients with OSAS who were regularly
seen in our outpatient clinic at the Department of Neur-
ology, Dokkyo Medical University and whose conditions
were at stable for at least 3 months were included in this
study. Figure 1 displays the flowchart for this study.
Initially, 277 consecutive outpatients with OSAS (219
men, 58 women; mean age, 55.2 ± 11.5 years) were
enrolled. Patients receiving oral appliance treatment(n = 4); patients with other comorbid primary sleep dis-
orders, such as rapid eye movement sleep behaviour dis-
orders (n = 3) and restless legs syndrome (RLS) (n = 6);
and patients with neurodegenerative diseases and
psychiatric disorders were excluded from the study. Pa-
tients with OSAS diagnosed by portable monitoring
were excluded (n = 5). Finally, 235 stable outpatients
with OSAS who were receiving CPAP therapy (190 men,
45 women; mean age, 54.8 ± 11.6 years) were included in
this study (Fig. 1).
OSAS was diagnosed on the basis of a clinical inter-
view and examination and in-laboratory full-night poly-
somnography (PSG), according to the International
Classification of Sleep Disorders, second edition (ICSD-
2) [8]. Obstructive sleep apnoea was defined as the
cessation of airflow for at least 10 s in the presence of
respiratory effort. Hypopnea was defined as a greater
than 50 % reduction of airflow for at least 10 s, a reduc-
tion in breathing of less than 50 %, greater than 3 % oxy-
gen desaturation (ODI) or arousal for more than 10 s.
ODI was calculated according to the number of oxygen
Fig. 1 Flow chart of the patient selection process. RBD, rapid eye movement sleep behaviour disorder; RLS, restless legs syndrome
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The apnoea-hypopnoea index (AHI) was calculated as
the average of the total number of apnoea and hypop-
noea episodes per hour of sleep. No patients had central
apnoea index greater than 5. Data were extracted from
PSG records and medical records. Of all of the patients,
225 patients (95.7 %) had an AHI of 20 or greater. Data
on daily CPAP usage and residual AHI after CPAP treat-
ment were obtained from CPAP memory cards for at
least 2 consecutive months after CPAP introduction. Ac-
ceptable CPAP compliance (% CPAP usage > 4 h/day)
was defined when the patient used CPAP > 4 h per night
for > 70 % of nights over at least 2 consecutive months.
CPAP responders were defined by residual AHI < 10.
All of the patients were asked about the presence and
characteristics (localisation, quality and intensity) of
morning headache (headache upon waking in the morn-
ing) by MM or KS during a face-to-face interview. In
addition, through review of the medical records before
administration of CPAP treatment, the presence of
morning headaches was confirmed. Patients who had a
headache after a nap or during sleep but not upon wak-
ing were not considered to have “morning headache” in
this study. If these patients reported having morning
headache, their headaches were classified as migraines,
tension-type headaches, cluster headaches or others
(unclassified type) according to the ICHD-2 criteria. For
headache characteristics, only headaches occurring upon
waking were assessed. Then, morning headaches were
assessed to determine whether they fulfilled the criteria
for “sleep apnoea headache” according to ICHD-3 beta
(sleep apnoea headache [ICHD-3 beta]) criteria [7], and
the differences with the ICHD-2 criteria [5] were evalu-
ated. Regarding the effectiveness of CPAP treatment onmorning headache, improvement of morning headache
after CPAP therapy was defined when headaches ceased
and did not recur after CPAP treatment.
Sleep disturbance, sleep quality and sleep habits were
assessed using the Japanese version of the Pittsburgh
Sleep Quality Index (PSQI). The following seven compo-
nent scores of the PSQI were also evaluated [9]: C1,
sleep quality; C2, sleep latency; C3, sleep duration; C4,
habitual sleep efficiency; C5, sleep disturbances; C6, use
of sleeping medications; and C7, daytime dysfunctions.
Daytime sleepiness was evaluated with the use of the
Japanese version of the Epworth Sleepiness Scale (ESS)
[10, 11]. The Beck Depression Inventory-II (BDI-II) was
employed to assess depressive symptoms [12].
Statistical analysis
The Mann–Whitney U-test or unpaired t-test was used
where appropriate to compare continuous variables, and
the chi-squared or Fisher’s exact test was performed to
compare the differences in frequencies between two
groups. The significance of the differences was defined
using a two-tailed t-test with p < 0.05. A commercially
available software package (IBM SPSS Statics 21.0,
Tokyo, Japan) was used for the statistical analyses.
Results
Of 235 OSAS patients, 48 (20.4 %) reported morning
headaches. Of the 48 patients with morning headache,
25.0 % had a headache frequency greater than 15 days
per month, 41.7 % had pressing and bilateral headache
not accompanied by nausea, photophobia or phonopho-
bia, 31.3 % had a headache of short duration (<30 min),
and 81.3 % reported improvement in their headaches
after CPAP treatment. Overall, 29 patients (60.4 %)
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headache (Table 1). When the ICHD-3 beta criteria for
sleep apnoea headache were used, 81.3 % patients with
morning headache fulfilled the sleep apnoea headache
criteria (Table 2). In particular, 10 patients with morning
headache who responded well to CPAP treatment did
not fulfil the ICHD-2 criteria because their headache du-
rations were longer than 30 min. However, when the
ICHD-3 beta criteria were applied, all of these patients
were diagnosed with “sleep apnoea headache”.
Table 3 displays the clinical characteristics of the pa-
tients with sleep apnoea headache, according to the
ICHD-2 and ICHD-3 beta criteria. Patients with sleep
apnoea headache were younger and had higher BMI and
more severe depressive symptoms than those without
sleep apnoea headache. However, CPAP adherence and
PSG parameters, such as AHI, 3 % ODI and arousal
index, were similar between the groups.
OSAS patients with morning headache (n = 48) had
the following characteristics: migraine, 12 (25.0 %);
tension-type headache, 19 (39.6 %); cluster headache, 1
(2.1 %); and others (unclassified), 16 (33.3 %). Of the 12
patients with migraine characteristics, 7 (58.3 %) and 8
(66.7 %) had a diagnosis of sleep apnoea headache
according to the ICHD-2 and ICHD-3 beta criteria, re-
spectively. In contrast, of the 19 patients with tension-
type headache characteristics, 12 (63.2 %) and 16
(84.2 %) had a diagnosis of sleep apnoea headache ac-
cording to the ICHD-2 and ICHD-3 beta criteria, re-
spectively. Of OSAS patients with unclassified types of
morning headache (n = 16), 9 (56.3 %) and 14 (87.5 %)
had a sole diagnosis of sleep apnoea headache according
to the ICHD-2 and ICHD-3 beta criteria, respectively.
Discussion
To the best of our knowledge, this study is the first to
compare the sensitivity of the ICHD-3 beta criteria for
“sleep apnoea headache” in OSAS patients with morning
headaches. In our study, we assessed headaches upon
awakening in the morning but not headaches upon
awakening during sleep or after a nap because the
ICHD-3 beta criteria clearly state that a sleep apnoea
headache is a morning headache caused by sleep apnoea.
This study demonstrated that 60.4 % and 81.3 % of pa-
tients with morning headache met the criteria for “sleep
apnoea headache” established by ICHD-2 and ICHD-3
beta, respectively (Tables 1 and 2). The increased fre-
quency of individuals who qualified for diagnosis was
likely attributable to the extension of headache duration
from 30 min to 4 h. This modification had clinical sig-
nificance, as demonstrated in this study. Out of all
morning headaches (n = 48), 81.3 % (n = 39) responded
to CPAP therapy, and 19.7 % (n = 10) of the CPAP-
treatable morning headaches did not fulfil the ICHD-2criteria, although they all fulfilled the ICHD-3 beta criteria
for “sleep apnoea headache”. Previous studies have demon-
strated that 80-90 % of morning headaches improved after
appropriate treatment (CPAP or uvulopalatopharyngoplasty)
for OSAS [1, 13]. Among habitual snorers, 32 % of all
morning headaches lasted less than 30 min [6]; in our
study of OSAS patients, 31.3 % of all morning headaches
lasted less than 30 min. In other studies, the proportions
of morning headaches lasting less than 1 h were 26.3 %
[14] and 26.7 % [1] in OSAS patients. In our study, the
proportion of morning headaches resolving within 4 h,
that is, the duration specified by the ICHD-3 beta criteria,
increased to 52.1 %.
Kristiansen et al. [15] recently reported an increased
frequency of morning headache in participants with
OSAS (11.8 %) compared with those without OSAS
(4.16 %) in the general population. The frequency of
morning headache (20.4 %) in our study was lower than
previously reported in patients with OSAS (18-60 %)
[1–3, 14, 16–18]. The proportion of total OSAS patients
in this study who had sleep apnoea headache was 12.3 %
and 16.6 % based on ICHD-2 and ICHD-3 beta, respect-
ively; similarly, the latest review reports a prevalence of
sleep apnoea headache of 12-18 % in the middle-aged
population [19]. Göder et al. [20] compared PSG record-
ings from the nights before morning headaches with
those from nights that were not followed by morning
headaches in patients with OSAS, and they showed that
the occurrence of a morning headache was associated
with decreases in total sleep time, sleep efficiency and
the amount of rapid eye movement sleep as well as with
an increase in awake time during the preceding night.
Oxygen desaturation and AHI did not differ when nights
with and without subsequent morning headaches were
compared. In our previous study including 36 OSAS pa-
tients, PaCO2 values upon waking did not significantly
differ between patients with and without morning head-
aches [21]. In contrast, Aldrich and Chauncey [2] evalu-
ated the frequency and characteristics of morning
headaches in various sleep disorders, including OSAS,
but they failed to find a significant association between
morning headaches and OSAS. The possible mecha-
nisms of sleep apnoea headache include repeated
respiratory events, nocturnal hypoxia, hypercapnia-
induced vasodilation and increased intracranial pressure
[3, 13, 22]. Our study did not support a role of nocturnal
hypoxia in the development of sleep apnoea headaches
or morning headaches in OSAS patients because the
PSG parameters, including AHI and nocturnal oxygen
desaturation, did not differ depending on whether the
patient had sleep apnoea headaches or morning
headaches.
Another important finding in our study is that OSAS
patients with morning headache frequently exhibited
Table 3 Comparison of clinical features of patients with and without sleep apnoea headache
ICHD-2 p value ICHD-3 beta p value
Sleep apnoea
headache (n = 29)
No sleep apnoea
headache (n = 206)
Sleep apnoea
headache (n = 39)
No sleep apnoea
headache (n = 196)
Age (years) 50.4 ± 10.6 55.4 ± 11.6 0.028 49.3 ± 10.1 55.9 ± 11.6 0.0012
BMI (kg/m2) 31.7 ± 10.0 28.2 ± 7.3 0.084 31.5 ± 9.0 28.1 ± 7.4 0.011
Sex (M/F) 21/8 169/37 0.22 30/9 160/36 0.50
Education (years) 14.6 ± 2.9 13.3 ± 2.7 0.028 14.8 ± 3.4 13.2 ± 2.6 0.0073
Caffeine (cup/day) 2.6 ± 1.9 2.9 ± 2.6 0.54 2.7 ± 1.8 2.9 ± 2.6 0.73
Smoking, n (%) 0.28 0.17
Never 9 (31.0) 87 (42.2) 13 (33.3) 83 (42.3)
Past 12 (41.4) 85 (41.3) 15 (38.5) 82 (41.8)
Current 8 (27.6) 34 (16.5) 11 (28.2) 31 (15.8)
Alcohol, n (%) 0.040 0.0057
Never 8 (27.6) 70 (34.0) 11 (28.2) 67 (34.2)
< 1 day/week 14 (48.3) 50 (24.3) 19 (48.7) 45 (23.0)
1-2 days/week 4 (13.8) 22 (10.7) 5 (12.8) 21 (10.7)
3-5 days/week 2 (6.9) 27 (13.1) 3 (7.7) 26 (13.3)
6-7 days/week 1 (3.4) 37 (18.0) 1 (2.6) 37 (18.9)
AHI (/h) (before CPAP
treatment)
51.6 ± 22.6 55.3 ± 25.2 0.46 56.6 ± 24.9 54.5 ± 24.9 0.63
3 % ODI (/h) 41.5 ± 23.7 45.4 ± 26.6 0.47 46.9 ± 26.7 44.5 ± 26.2 0.61
Arousal index (/h) 47.0 ± 17.5 56.1 ± 48.1 0.41 51.3 ± 20.6 55.7 ± 48.9 0.66
Morning headache 29 (100) 19 (9.2) <0.001 39 (100) 9 (4.6) <0.001
ESS (before CPAP treatment) 8.7 ± 4.7 8.5 ± 5.2 0.88 8.6 ± 4.6 8.5 ± 5.3 0.90
PSQI global score 5.8 ± 2.6 5.1 ± 3.1 0.23 5.9 ± 2.9 5.0 ± 3.0 0.085
PSQI component score
C1, Sleep quality 1.4 ± 0.6 1.1 ± 0.7 0.052 1.3 ± 0.7 1.1 ± 0.7 0.064
C2, Sleep latency 0.8 ± 1.0 0.6 ± 0.9 0.52 0.8 ± 1.0 0.6 ± 0.9 0.28
C3, Sleep duration 1.4 ± 0.9 1.1 ± 0.9 0.055 1.4 ± 0.9 1.1 ± 0.9 0.062
C4, Habitual sleep efficiency 0.3 ± 0.7 0.2 ± 0.7 0.48 0.3 ± 0.6 0.2 ± 0.7 0.80
C5, Sleep disturbances 1.0 ± 0.6 0.9 ± 0.5 0.20 0.9 ± 0.6 0.9 ± 0.5 0.39
C6, Use of sleeping
medication
0.3 ± 0.8 0.4 ± 1.0 0.54 0.5 ± 1.0 0.4 ± 1.0 0.51
C7, Daytime dysfunction 0.7 ± 0.8 0.7 ± 0.9 0.62 0.7 ± 0.8 0.7 ± 0.9 0.93
BDI-II 11.4 ± 6.9 9.1 ± 7.3 0.10 11.5 ± 7.1 8.9 ± 7.3 0.042
Residual AHI after CPAP
treatment (/h)a
3.5 ± 2.3 3.7 ± 2.5 0.67 3.6 ± 2.5 3.7 ± 2.4 0.88
CPAP responders (residual
AHI < 10), n (%)
29 (100) 202 (98.1) 1.0 38 (97.4) 193 (98.5) 0.65
CPAP treatment period (/m) 29.0 ± 29.4 36.4 ± 29.0 0.20 29.2 ± 28 36.8 ± 29.2 0.14
Daily CPAP use (h) 5:03 ± 1:24 5:04 ± 1:38 0.98 4:45 ± 1:33 5:07 ± 1:36 0.19
CPAP usage > 4 h/d, n (%) 16 (55.2) 106 (51.5) 0.71 19 (48.7) 103 (52.6) 0.66
The data are shown as n (number or %) or mean ± SD. Statistically significant values (p < 0.05) are shown in bold
AHI apnoea-hypopnoea index, BDI-II Beck Depression Inventory-II, CPAP continuous positive airway pressure, ESS Epworth Sleepiness Scale, ODI oxygen
desaturation index, PSQI Pittsburgh Sleep Quality Index
aResidual AHI was obtained from CPAP memory cards
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Furthermore, a significant number of morning headache
patients having characteristics of migraine and tension-
type headaches were diagnosed as having sleep apnoea
headache. This finding suggests that for patients with
OSAS, CPAP therapy can effectively treat not only
morning headaches with tension-type features but also
morning headaches with migraine-like features. By con-
trast, Chen et al. [6] found that morning headaches were
more strongly associated with migraines (adjusted odds
ratio, 6.3) than with OSAS (adjusted odds ratio, 2.6) in
habitual snorers. The authors suggested that for habitual
snorers, managing migraines and insomnia may be more
helpful for morning headaches than managing OSAS. In
the study including 4759 patients with OSAS from the
Taiwan Longitudinal Health Insurance Database, OSAS
patients had a higher likelihood of developing tension-
type headache than did patients without OSAS [23].
However, the authors did not assess the presence of
morning headache and whether tension-type headache
was associated with morning headache. Johnson et al.
[4] reported that of 82 chronic headache patients with
migraine or tension-type headache or both, 63 % had
concomitant OSAS.
The limitations of our study included the cross-
sectional study design and the lack of a healthy control
group. In this study, all of the OSAS patients were under
CPAP treatment; therefore, the headache frequencies re-
ported by the patients might have been underestimated
due to the efficacy of CPAP therapy. However, the
strength of this study is that sleep apnoea headaches were
diagnosed after a confirmation of the effectiveness of
CPAP on headaches, which could eliminate other head-
aches that mimicked sleep apnoea headaches; in the previ-
ous studies, morning headaches were evaluated before
confirming the effectiveness of CPAP on headaches [6], or
the CPAP effects on sleep apnoea headaches were evalu-
ated in a limited number of OSAS patients [1, 3, 13]. In
our study, most of the patients had an AHI of 20 or
greater, likely because we selected stable OSAS patients
receiving CPAP therapy who visited our outpatient clinic
every month, and in Japan, CPAP use is generally re-
stricted to OSAS patients with AHI ≥ 20. Further investi-
gations are needed to evaluate sleep apnoea headache in
OSAS patients with AHI < 20. A further prospective study
is required to assess the associations between morning
headaches and OSAS.
Conclusions
The utilisation of ICHD-3 beta criteria is clinically useful
for diagnosing sleep apnoea headache in patients with
OSAS. The increased frequency of individuals who
qualified for diagnosis of sleep apnoea headache is cer-
tainly of clinical significance when considering themarked response to CPAP therapy. Our study also
showed that sleep apnoea headache was not related to
OSAS severity. The cause of sleep apnoea headache
remains to be elucidated.
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